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ABSTRACT 
 
Purpose: To report an investigation of an outbreak of Ochrobactrum anthropi 
endophthalmitis following cataract surgery and propose a new sterilization 
protocol to minimize the risk of further cases in the operating environment. 
Setting: Hospital das Clínicas, Federal University of Espírito Santo School of 
Medicine, Vitória, Espírito Santo, Brazil. 
Design: Noncomparative consecutive case series. 
Methods: The medical records of patients with culture proven O. anthropi 
endophthalmitis or with suggestive clinical findings during the outbreak, but 
without microbiological confirmation, were reviewed.  We also surveyed existing 
protocols for disinfection and sterilization of surgical materials and discussed 
their proper application in the hospital routine. 
Results: Seven cases of O. anthropi pseudophakic endophthalmitis were 
confirmed between July 24 and November 10, 2010. The average interval 
between surgery and diagnosis was 5 days. Initial therapy with intravitreal 
injection of vancomycin and amikacin proved ineffective in 5 of 7 cases (71%). 
Complications included macular hole, fibrosis in the macula, retinal vein branch 
occlusion, retinal ischemia and diffuse hemorrhage, retinal necrosis and phthisis 
bulbi. Final visual acuity was counting fingers or worse in five patients. 
Conclusions: Pars plana vitrectomy with partial capsulectomy appeared to be 
curative in 2 of 3 surgical cases that could be followed. The most likely cause of 
this outbreak was contamination of the tubing kit of the phacoemulsification 
machine. Following introduction of a new sterilization protocol involving the use 
of an enzymatic detergent and more vigorous cleaning of the tubing with 
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distilled water, no further cases were reported in over a thousand subsequent 
procedures. 
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PURPOSE 
 
Endophthalmitis is a potentially severe intraocular inflammation which 
may occur as a complication of intraocular surgery or as a result of nonsurgical 
trauma or systemic infection. Irreversible photoreceptor cell damage is a 
frequent occurrence, even with prompt and proper therapeutic intervention.1 
Postoperative endophthalmitis occurs most frequently following cataract 
surgery, with a reported incidence ranging from 0.02 to 0.3%.1-8 
Depending on the time of onset, endophthalmitis may be classified as 
acute or chronic. The former occurs early (hours or days after surgery) and is 
caused by virulent organisms. It is often associated with hypopyon and severe 
inflammation with a commonly aggressive clinical course.8-10 The latter is an 
unusual complication of cataract surgery but well documented in several small 
series. It is caused by less virulent organisms and the clinical condition is a 
recurrent, often low-grade uveitis which partially responds to topical or systemic 
steroids.8-10 The indolent course of chronic endophthalmitis is sometimes 
difficult to distinguish from a persistent postoperative inflammation. It may 
develop months or even years after the initial surgical event and commonly 
presents itself with mild pain, granulomatous uveitis with or without hypopyon, 
vitreous activity, capsular thickening or plaque and visual loss.8-10 
In this study, we report the clinical aspects of an endophthalmitis 
outbreak following cataract surgery secondary to Ochrobactrum anthropi at 
Hospital das Clínicas in Vitória (a state capital of Southeastern Brazil). Our 
cases differ from the few previously reported cases in many aspects. Surgical 
management, antibiotic sensitivity and visual outcome are discussed. The 
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literature was reviewed in order to develop a sterilization protocol capable of 
minimizing the risk of further outbreaks in the operating environment. 
 
 
MATERIALS AND METHODS 
 
This is an observational case series study. All patients presented with 
endophthalmitis following cataract surgery with intraocular lens implantation 
(IOL) between July 24 and November 10 at Hospital das Clínicas (Vitória, 
Brazil). The medical records of seven patients with culture-proven O. anthropi 
endophthalmitis or suspected cases without microbiological confirmation 
observed during the outbreak were reviewed and the clinical presentation of 
these patients was compared to the few reports found in the literature. We also 
surveyed existing protocols for disinfection and sterilization of surgical materials 
and discuss their proper application in the hospital routine. 
 
 
RESULTS 
 
All patients underwent phacoemulsification with IOL implantation into the 
capsular bag. There were no complications during any of these surgeries. A 
sterile drape with an adhesive foil was used to remove the eyelashes from the 
operative field. Povidone-iodine was administered topically prior to surgery. 
Prior to the endophthalmitis outbreak, the tubing kit of the 
phacoemulsification machine was used in 3 cataract surgeries per day. Only the 
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phaco probe was exchanged between surgeries. Disinfection of the tubing kit 
was performed according to the manufacturer's recommendations (Allergan®) 
and the material was autoclaved at the hospital´s central sterilization facility. 
A total of 140 patients were submitted to surgery in the same operating 
room between the first and last detected case of endophthalmitis, following the 
routine procedures described above. However, only 7 patients develop signs or 
symptoms suggestive of endophthalmitis. 
All patients were initially treated with empiric administration of 0.4 mg 
amikacin + 1 mg vancomycin + 0.4 mg dexamethasone (IV AVD; 0.1mL each). 
Vitreous samples were collected and plated on blood agar, chocolate agar, 
Sabouraud dextrose agar, thioglycollate broth and anaerobic medium. Gram 
was also performed. Antibiograms were performed in all cases for clinical 
guidance. Bacterial resistance was evaluated, but since O. anthropi has not 
been standardized by the Clinical Laboratory Standard Institute (CLSI) – the 
method used in our department of microbiology – the respective levels of 
sensitivity could not be determined. 
Table 1 is a summary of patient data. 
 
Case 1 
A 73-year-old woman was submitted to surgery in the left eye (OS) on 
July 24. On the day after surgery, an anterior chamber inflammation was 
observed with flare (1+) and cells (2-3+), in addition to a fibrinous pupillary 
membrane. Steroid therapy was started. On the following day, the ocular 
inflammation worsened. A clinical diagnosis of endophthalmitis was established 
and the patient was treated with IV AVD. O. anthropi was isolated in culture. The 
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patient experienced visual improvement but white granular debris was noticed 
in the lower portion of the IOL. 
On September 16, signs and symptoms of endophthalmitis were seen 
again and a new course of intravitreal antibiotics was initiated. One week later, 
a branch vein obstruction near the macula was observed. 
Clinical follow-up showed complete reduction of intraocular inflammation, 
but on October 13 endophthalmitis recurred. On the following day, a pars plana 
vitrectomy (PPV) with partial capsulectomy (PC) plus meropenem injection and 
silicone oil was done. An area of necrosis in the periphery of the lower retina 
was observed and endolaser photocoagulation was performed to surround the 
lesion. This time there was no recurrence. 
 
Case 2 
A 59-year-old woman was submitted to surgery in the right eye (OD) on 
July 30. The patient complained of blurred vision on the tenth day after the 
surgery but only sought medical care 3 weeks later. She reported no pain during 
all this period. The examination showed a moderate vitritis with no anterior 
chamber activity. Due to only partial response to 3 weeks of steroid therapy, IV 
AVD was administered on September 22. O. anthropi was isolated in culture. 
No recurrence has been observed so far. 
 
Case 3 
A 79-year-old man was submitted to surgery in the OS on August 20. He 
began to complain of mild ocular pain and reduced visual acuity on the seventh 
day post-surgery (POD). The examination revealed corneal edema (3+), 
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anterior chamber inflammation with flare (1+) and cells (2+), mild hypopyon and 
prominent vitritis. Clinical improvement was observed after treatment with IV 
AVD. O. anthropi was isolated in culture. 
On October 18, the patient experienced another visual deterioration. On 
ophthalmoscopy, diffuse retinal hemorrhage was seen on the posterior pole, 
with moderate vitreous haze. No sign of endophthalmitis was observed this 
time. 
 
Case 4 
A 77-year-old woman was submitted to surgery in the OS on August 25. 
On POD 6, despite the absence of ocular pain, fibrin in the anterior chamber, 
cells (2-3+), flare (1+) and mild hypopyon associated with the fibrinous pupillary 
membrane were observed (Figure 1). The patient was treated with IV AVD. O. 
anthropi was isolated in culture. 
On September 29, the patient experienced a recurrence with anterior 
chamber inflammation (cells 3-4+), diffuse keratic precipitates, posterior 
synechiae and vitreous haze. A new course of amikacin and dexamethasone 
was initiated. Despite treatment, the patient developed dense and diffuse fibrin 
and hypopyon occupying one third of the anterior chamber. Antibiogram testing 
of the second sample indicated resistance to amikacin. 
On October 20, PPV with PC plus injection of meropenem and silicone oil 
was performed. A large area of necrosis was observed in the lower retina and 
endolaser photocoagulation was used to surround the lesion. The inflammatory 
process persisted, with recurrence of hypopyon. On November 22, the patient 
was submitted to PPV with total capsulectomy, lensectomy and silicone oil 
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removal and a new application of meropenem. The affected eye progressed to 
amaurosis and phthisis bulbi. 
 
Case 5  
A 76-year-old woman was submitted to surgery in the OD on September 
1. On the fourth day after surgery the patient complained of mild ocular pain 
associated with decreased vision. Biomicroscopy showed anterior chamber 
inflammation with cells (2+), flare (2-3+), linear hypopyon and fibrin at the 
pupillary edge. Given the uncertainty about etiology of the inflammation, steroid 
therapy was initiated. On the following day the hypopyon disappeared and 
visual acuity improved. 
Five weeks after the surgery it was not yet possible to visualize the 
ocular fundus due to vitreous haze. On October 6, the patient started treatment 
with IV AVD, but no material was collected due to dry aspiration. 
After a chronic intraocular inflammation with 3 episodes of exacerbation 
that partially responded to topical steroids, the patient was submitted to PPV on 
February 8, including intravitreal application of amikacin and ceftazidime. During 
the surgery, pallor of the optic nerve was noticed. O. anthropi was isolated in 
culture. 
The patient experienced good visual clinical improvement but died 
secondary to a proximal femoral fracture. 
 
Case 6 
A 60-year-old woman was submitted to surgery in the OS on September 
27. On POD 3, the patient complained of ocular pain and decreased visual 
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acuity. The examination revealed corneal edema (3+), anterior chamber 
inflammation with flare (1+) and cells (1+), fibrinous pupillary membrane and 
prominent vitritis. IV AVD was administered. No organism grew in the culture. 
Following the resolution of the inflammatory process on the 11th day, cotton-
wool spots, retinal hemorrhages and a macular hole were observed (Figure 2). 
The patient was subsequently lost to follow-up. 
 
Case 7 
A 71-year-old man was submitted to surgery in the OS on November 10. 
Six days later, severe eye pain and marked ocular inflammation with hypopyon 
occupying one third of the anterior chamber and fibrinous pupillary membrane 
was observed. The patient was treated with IV AVD. O. anthropi was isolated in 
culture. Considerable anterior chamber activity with no pain was still observed 
after three weeks. On ultrasound, small vacuoles were seen in the vitreous 
cavity. A new intravitreal injection of amikacin + dexamethasone was 
administered. 
On December 18 the patient returned with severe ocular inflammation 
and pain again and was submitted to PPV with intravitreal meropenem and 
dexamethasone injection. During the surgical procedure, severe vitreous 
hemorrhage, many areas of retinal hemorrhage and macular fibrosis were 
observed. The patient was treated with panretinal endolaser photocoagulation 
and bevacizumab. A month later, endophthalmitis recurred and the patient was 
submitted to PPV with lensectomy and application of meropenem. The clinical 
follow-up revealed proliferative vitreoretinopathy followed later by vitreous 
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hemorrhage. On June 3, the OS was eviscerated due to the persistence of the 
inflammatory process. 
 
Since O. anthropi had not previously been isolated in our hospital, the 
protocols of infection control were instituted only when the Department of 
Ophthalmology became aware of a second case (case 4, September 2). The 
ophthalmic operating room was closed for 3 weeks while individual cases and 
the literature were reviewed. 
We replaced several materials and supplies suspected of being the 
source of contamination, including IOL, mydriatic eyedrops, povidone-iodine 
solution and viscoelastic and balanced salt solution. Samples of these materials 
were submitted to laboratory analysis. In addition, all sterilization procedures 
and routines of the operating room were reviewed. 
Safety precautions were taken and cataract surgeries restarted. 
However, six weeks later a new case of O. anthropi endophthalmitis (case 7) 
was identified. Another patient (case 6), submitted to surgery only four days 
after the operating room was reopened, was not diagnosed until the following 
year. The only point in common with the other surgeries was the tubing kit of the 
phacoemulsification machine. Flushings were then collected from four sets (all 
in use at the time) and submitted to culture along with the tubing. Fluid was 
collected both when flowing through the irrigation system and when returning 
from the aspiration system and drainage bag, pumping it both ways through the 
phaco probe. 
While completing the purchase of new sets, we performed extracapsular 
cataract extraction with lens implantation without further cases of 
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endophthalmitis. The situation was maintained after the resumption of 
phacoemulsification surgery. 
All samples of materials sent to the microbiology laboratory had negative 
cultures. The Committee of Hospital Infection Control concluded that no specific 
cause could be identified, but contamination of the tubing kit is the most 
plausible explanation. 
 
 
DISCUSSION 
 
O. anthropi is a ubiquitous gram-negative, non-fastidious, highly motile, 
non-lactose fermenting bacillus with strictly oxidative metabolism and very 
active urease11-23 found mainly in water sources (including normal saline, 
antiseptic solutions and dialysis liquids).10-13 It is therefore likely to occupy the 
same microbial niche as Pseudomonas species.14 The average time required to 
grow of the cultures was 5 days in our cases (range: 4–6 days), which is 
consistent with previous reports.12 
O. anthropi infrequently causes human infection, usually associated with 
immunocompromised hosts and indwelling catheters.13-21 This may be due to its 
ability to adhere to various synthetic materials such as IOL and silicone tubing 
(demonstrated by in vitro experiments).22 In 1980, the first case of human 
infection with O. anthropi was described in a patient with a pancreatic 
abscess.11 Since then, the pathogen has been described in six reported cases 
of endophthalmitis following intraocular surgery12,13,18,19,23 or by endogenous 
spread,20 with a total of 14 patients affected. 
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The interval between cataract surgery and onset of signs and symptoms 
of endophthalmitis in this report ranged from 1–10 days (average: 5 days). This 
period was shorter than in previous studies (average: 6 weeks; range: 9-70 
days).12,18,19,23 
The clinical presenting signs were similar to O. anthropi pseudophakic 
endophthalmitis reported in the literature. The main presenting features were 
decreased vision (7/7), anterior chamber reaction (6/7), vitritis (7/7), hypopyon 
(5/7) and fibrinous pupillary membrane (4/7). However, the severity of disease 
found in this study contradicted the low virulence observed in previous 
reports.12,18,19,23 Final visual acuity was counting fingers or worse in 85% of 
patients (6/7) after the final clinical follow-up in this report, contrasting with the 
much better visual outcome observed in the literature (20/60 or better in 11 of 
14 patients). Moreover, ocular complications occurred which had never been 
described in O. anthropi endophthalmitis, such as macular hole, venous 
occlusion, cotton-wool spots, retinal hemorrhage, necrosis and 
neovascularization. These findings may account for the poor visual acuity of our 
patients and suggest an underlying vasculitis or perivasculitis. 
Several studies have shown that microorganisms can be isolated from 
the anterior chamber at the end of cataract surgery in 5 to 43% of patients.24-28 
This fact does not necessarily imply infection, suggesting that natural defense 
mechanisms are capable of eliminating small inocula of bacteria of low 
pathogenicity thereby preventing the development of endophthalmitis.7 This 
appears to be the case of O. anthropi, which, despite the severity of our cases, 
presented an attack rate of approximately 5% during the period of the outbreak, 
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considering individuals at submitted to phacoemulsification in any intraocular 
surgery. 
All patients had vision of hand motions or better at the initial presentation. 
Following the guidelines of the Endophthalmitis Vitrectomy Study Group,29-33 
patients initially received empiric treatment with intravitreal antibiotics plus 
dexamethasone, and vitreous samples were collected for microbiological 
investigation. The use of aminoglycosides in our hospital is due to its 
bactericidal dose-dependent action (even at high concentrations of germs) and 
synergism with vancomycin – characteristics not observed with ceftazidime.34 
The use of intravitreal corticosteroids in the management of 
endophthalmitis remains controversial.35 However, several clinical and 
experimental reports suggest that intravitreal corticosteroid therapy used in 
conjunction with antibiotics may reduce the intraocular inflammatory process 
and secondary complications associated with microbial endophthalmitis.34-36 
In this report, initial therapy with intravitreal injection of antibiotics proved 
ineffective in 5 of 7cases (71%). PPV combined with PC, or even total 
capsulectomy and IOL removal, as described in the literature, does seem to be 
curative.12,19,23 Innate resistance to antibiotics11-23 and sequestration in the 
capsular bag12,19,23 justify the need for these additional procedures. A factor 
probably responsible for this situation is the formation of a biofilm,37,38 a 
functional consortium of micro-organisms organized within an extensive 
exopolymer matrix39 which confers relative protection from humoral and cellular 
immunity and from antibiotics.3 In addition, Griffiths et al40 found that adherence 
of Staphylococcus epidermidis to IOLs in vitro appears to confer greater 
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resistance to antibiotics, while Cusumano et al41 demonstrated that bacterial 
growth in vitro is significantly enhanced on silicone IOLs. 
Perhaps in an attempt to reduce costs and increase the efficiency of the 
phacoemulsification machine, it is common practice to use a single tubing kit to 
perform multiple cataract surgeries on the same day, exchanging only the 
phaco probe (or simply the phaco tip) between surgeries. However, silicone 
material has been shown to allow adhesion of bacteria and other 
biomaterials22,41,42 and in some studies standard cleaning regimes were shown 
not to be completely effective at removing debris from previous surgeries.4,43 
Various contaminants were identified, including lens capsule and cells, man-
made fibers, squamous cells, bacteria, fungal elements, diatoms, red blood 
cells and proteinaceous material.4 The presence of organic debris on 
instruments interferes with the sterilization process as it insulates the organisms 
from the killing agent. This fact favors the formation of bacterial biofilm and puts 
patients at risk for cross-infection.44,45 This was probably the source of our 
outbreak of endophthalmitis. 
Due to the lack of an established cleaning and sterilization protocol in the 
literature,4,5,43,46,47a new protocol was designed at our hospital: the tubing is 
flushed with distilled water through the purge cycle of the phacoemulsification 
machine (repeated three times) immediately after each surgery, according to 
the manufacturer’s recommendations. Upon arrival at the central sterilization 
facility, the tubing is placed in an ultrasonic bath with a solution of enzymatic 
detergent (Maxzyme®) at 50 ºC for 10 minutes to remove the debris before 
sterilization. The tubing is subsequently washed with water, cleaned with 
compressed air and placed in the autoclave. All tubing kits are submitted to 
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sterility assurance level testing and are sent to the microbiology laboratory to 
search for microbial contamination after being used twenty times. 
Intraocular surgery using the phacoemulsification machine was 
recommenced following the implementation of the above sterilization protocol. 
At the time of writing, 1008 cataract surgeries have been performed without a 
single case of postoperative endophthalmitis and no further contamination of 
the tubing kits. 
It is also worthy of mention that following the implementation of the new 
protocol, no cases of Toxic Anterior Segment Syndrome48,49 have been 
observed at our hospital despite the use of materials and procedures known to 
be implicated with this syndrome, such as enzymatic detergents and ultrasonic 
cleaning. 
 
CONCLUSION 
 
This report describes a series of cases of O. anthropi endophthalmitis 
with unusually severe outcomes, including several complications never reported 
in the literature. Inefficient sterilization can be a source of endophthalmitis 
outbreaks. However, it seems cross-infection can be prevented by vigorous 
cleaning of the tubing with distilled water and ultrasonic cleaning using an 
enzymatic detergent to remove the debris before sterilization to prevent the 
formation of bacterial biofilm. Cataract surgery represents a substantial cost to 
health care systems around the world. The new sterilization protocol proposed 
in this paper offers improved safety when reusing tubing in phacoemulsification. 
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WHAT WAS KNOWN 
* Only 14 cases of Ochrobactrum anthropi endophthalmitis were reported in the 
literature at the time of writing. Usually, this bacteria cause subacute or chronic 
disease that evaluated with a good visual outcome. 
* Silicone material has been shown to allow adhesion of bacteria and other 
biomaterials and in some studies standard cleaning regimes were shown not to 
be completely effective at removing debris from previous surgeries. 
 
WHAT THIS PAPER ADDS 
* Our observations differ from previously reported cases of O. anthropi 
pseudophakic endophthalmitis due to the shorter time of onset of signs and 
symptoms, the severity of the disease and complications not previously 
reported. 
* Cataract surgery represents a substantial cost to health care systems around 
the world. Persistence in the practice of reusing tubing is controversial and 
requires risk-benefit analysis at every hospital or clinic that performs cataract 
surgery. The new sterilization protocol proposed in this paper offers improved 
safety when reusing tubing in phacoemulsification. 
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FIGURE LEGEND 
 
FIGURE 1: Visualization of pupillary membrane and small hypopyon on 
slit lamp examination of case 4. 
  
FIGURE 2: Cotton-wool spots, retinal hemorrhages and a macular hole 
are observed on fundus examination of case 6. 
